133 related articles for article (PubMed ID: 24482501)
1. Correcting 2 more myths regarding transplants for AML in second remission.
Gale RP; Lazarus HM
Blood; 2014 Jan; 123(5):794. PubMed ID: 24482501
[No Abstract] [Full Text] [Related]
2. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
3. Stem cell transplantation in acute leukemia.
Gorin NC
Ann N Y Acad Sci; 1995 Dec; 770():262-87. PubMed ID: 8597366
[No Abstract] [Full Text] [Related]
4. Bone marrow transplantation in first remission.
Rowe JM
Leukemia; 1997 May; 11 Suppl 4():S12-4. PubMed ID: 9179274
[TBL] [Abstract][Full Text] [Related]
5. Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
Jabo B; Morgan JW; Martinez ME; Ghamsary M; Wieduwilt MJ
PLoS One; 2017; 12(4):e0174760. PubMed ID: 28384176
[TBL] [Abstract][Full Text] [Related]
6. Novel drug targets in acute leukemia.
Stock W
Clin Adv Hematol Oncol; 2015 Aug; 13(8):493-5. PubMed ID: 26351809
[No Abstract] [Full Text] [Related]
7. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia.
Tischer J; Stemmler HJ; Engel N; Hubmann M; Fritsch S; Prevalsek D; Schulz C; Zoellner AK; Bücklein V; Hill W; Ledderose G; Hausmann A
Ann Hematol; 2013 Oct; 92(10):1379-88. PubMed ID: 23928857
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia.
Zhang BL; Zhou J; Lyu TX; Gui RR; Zu YL; Yu FK; Zhao HF; Li Z; Wang J; Zhang YL; Zhang WL; Fu YW; Wei XD; Fang BJ; Li YF; Zhou KS; Song YP
Chin Med J (Engl); 2019 Apr; 132(7):860-864. PubMed ID: 30897600
[No Abstract] [Full Text] [Related]
10. Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
Keil F; Prinz E; Kalhs P; Lechner K; Moser K; Schwarzinger I; Jäger U; Fonatsch C; Worel N; Mannhalter C; Rabitsch W; Loidolt H; Schulenburg A; Mitterbauer M; Höcker P; Greinix HT
Leukemia; 2001 Mar; 15(3):355-61. PubMed ID: 11237057
[TBL] [Abstract][Full Text] [Related]
11. [Indication and results of hematopoietic stem cell transplantation. 1. Acute leukemia].
Ikeda K; Harada M
Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1464-9. PubMed ID: 9780672
[No Abstract] [Full Text] [Related]
12. Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemia.
Appelbaum FR
Best Pract Res Clin Haematol; 2013 Sep; 26(3):279-84. PubMed ID: 24309531
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
Juliusson G; Karlsson K; Lazarevic VLj; Wahlin A; Brune M; Antunovic P; Derolf A; Hägglund H; Karbach H; Lehmann S; Möllgård L; Stockelberg D; Hallböök H; Höglund M;
Cancer; 2011 Sep; 117(18):4238-46. PubMed ID: 21387283
[TBL] [Abstract][Full Text] [Related]
14. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
[TBL] [Abstract][Full Text] [Related]
15. [Can acute leukemia be cured?].
Shen ZX; Sun HP
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):433-4. PubMed ID: 15854542
[No Abstract] [Full Text] [Related]
16. The role of peripheral blood stem cells as rescue after myeloablative therapy.
Reiffers J; Marit G; Boiron JM; Rice A; Bernard P; Vezon G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
[No Abstract] [Full Text] [Related]
17. [Progress of chemotherapy in adult acute leukemia].
Ohno R
Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
[TBL] [Abstract][Full Text] [Related]
18. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
[TBL] [Abstract][Full Text] [Related]
19. Preventing acute leukemia relapse after allogeneic transplants: how to move forward?
Rosko A; de Lima M
Biol Blood Marrow Transplant; 2013 Jan; 19(1):2-3. PubMed ID: 23290793
[No Abstract] [Full Text] [Related]
20. High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
de Lima M; van Besien K; Gajewski J; Khouri I; Andersson B; Korbling M; Champlin R; Giralt S
Bone Marrow Transplant; 2000 Aug; 26(3):333-8. PubMed ID: 10967575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
